These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 7510078)
1. Computer-guided concentration-controlled trials in autoimmune disorders. McMichael J; Lieberman R; Doyle H; McCauley J; van Thiel D; Thomson A; Fung J; Starzl TE Ther Drug Monit; 1993 Dec; 15(6):510-3. PubMed ID: 7510078 [TBL] [Abstract][Full Text] [Related]
2. An intelligent and cost-effective computer dosing system for individualizing FK506 therapy in transplantation and autoimmune disorders. McMichael J; Lieberman R; Doyle H; McCauley J; Fung J; Starzl TE J Clin Pharmacol; 1993 Jul; 33(7):599-605. PubMed ID: 7690046 [TBL] [Abstract][Full Text] [Related]
3. Computer-guided randomized concentration-controlled trials of tacrolimus in autoimmunity: multiple sclerosis and primary biliary cirrhosis. McMichael J; Lieberman R; McCauley J; Irish W; Marino I; Doyle H Ther Drug Monit; 1996 Aug; 18(4):435-7. PubMed ID: 8857564 [TBL] [Abstract][Full Text] [Related]
4. A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients. Shenoy S; Hardinger KL; Crippin J; Korenblat K; Lisker-Melman M; Lowell JA; Chapman W Liver Transpl; 2008 Feb; 14(2):173-80. PubMed ID: 18236391 [TBL] [Abstract][Full Text] [Related]
5. ISA 247: trans-ISA 247, trans-R 1524, ISA(TX)247, ISAtx 247, ISATx247, LX 211, LX211, R 1524, R-1524. Drugs R D; 2007; 8(2):103-12. PubMed ID: 17324008 [TBL] [Abstract][Full Text] [Related]
6. Falsely abnormally elevated blood trough concentration of tacrolimus measured by antibody-conjugated magnetic immunoassay in a renal transplant recipient: a case report. Toraishi T; Takeuchi H; Nakamura Y; Konno O; Yokoyama T; Iwamoto H; Hama K; Hirano T; Unezaki S; Okuyama K; Shimazu M Transplant Proc; 2012 Jan; 44(1):134-6. PubMed ID: 22310597 [TBL] [Abstract][Full Text] [Related]
7. [Clinical experience with FK 506]. Starzl TE; Abu-Elmagd K; Fung JJ; Todo S; Tzakis AG; McCauley J; Demetris AJ Presse Med; 1991 Nov; 20(40):1967-73. PubMed ID: 1722311 [TBL] [Abstract][Full Text] [Related]
8. [Prediction of blood tacrolimus concentration in liver transplantation recipients by artificial neural network]. Fu XH; Ye YF; Luo MJ; Hong XD; Chen XL; Yao QY; Rong YC; Ren B Yao Xue Xue Bao; 2012 Sep; 47(9):1134-40. PubMed ID: 23227541 [TBL] [Abstract][Full Text] [Related]
9. Role of pharmacokinetic-pharmacodynamic principles in rational and cost-effective drug development. Lieberman R; McMichael J Ther Drug Monit; 1996 Aug; 18(4):423-8. PubMed ID: 8857562 [TBL] [Abstract][Full Text] [Related]
10. The use of therapeutic drug monitoring to optimise immunosuppressive therapy. Tsunoda SM; Aweeka FT Clin Pharmacokinet; 1996 Feb; 30(2):107-40. PubMed ID: 8906895 [TBL] [Abstract][Full Text] [Related]
11. Japanese study of FK 506 on kidney transplantation: the benefit of monitoring the whole blood FK 506 concentration. Japanese FK 506 Study Group. Transplant Proc; 1991 Dec; 23(6):3085-8. PubMed ID: 1721367 [No Abstract] [Full Text] [Related]
12. [Treatment with tacrolimus in autoimmune diseases]. Sádaba B; Azanza JR; García Quetglas E; Fernández V Rev Med Univ Navarra; 2004; 48(3):24-38. PubMed ID: 15622922 [TBL] [Abstract][Full Text] [Related]
13. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation. Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103 [TBL] [Abstract][Full Text] [Related]
14. Limited sampling strategies for monitoring tacrolimus in pediatric liver transplant recipients. Delaloye JR; Kassir N; Lapeyraque AL; Alvarez F; Lallier M; Beaunoyer M; Labbé L; Théorêt Y; Litalien C Ther Drug Monit; 2011 Aug; 33(4):380-6. PubMed ID: 21743386 [TBL] [Abstract][Full Text] [Related]
15. Immunosuppression Modifications Based on an Immune Response Assay: Results of a Randomized, Controlled Trial. Ravaioli M; Neri F; Lazzarotto T; Bertuzzo VR; Di Gioia P; Stacchini G; Morelli MC; Ercolani G; Cescon M; Chiereghin A; Del Gaudio M; Cucchetti A; Pinna AD Transplantation; 2015 Aug; 99(8):1625-32. PubMed ID: 25757214 [TBL] [Abstract][Full Text] [Related]
16. Limited sampling strategy for estimating individual exposure of tacrolimus in pediatric kidney transplant patients. Zhao W; Fakhoury M; Baudouin V; Maisin A; Deschênes G; Jacqz-Aigrain E Ther Drug Monit; 2011 Dec; 33(6):681-7. PubMed ID: 22011724 [TBL] [Abstract][Full Text] [Related]
18. A randomized clinical trial of age and genotype-guided tacrolimus dosing after pediatric solid organ transplantation. Min S; Papaz T; Lafreniere-Roula M; Nalli N; Grasemann H; Schwartz SM; Kamath BM; Ng V; Parekh RS; Manlhiot C; Mital S Pediatr Transplant; 2018 Nov; 22(7):e13285. PubMed ID: 30178515 [TBL] [Abstract][Full Text] [Related]
19. Abbreviated tacrolimus area-under-the-curve monitoring for renal transplant recipients. Wong KM; Shek CC; Chau KF; Li CS Am J Kidney Dis; 2000 Apr; 35(4):660-6. PubMed ID: 10739787 [TBL] [Abstract][Full Text] [Related]
20. A UK analysis of the cost of switching renal transplant patients from an immediate-release to a prolonged-release formulation of tacrolimus based on differences in trough concentration variability. Muduma G; Odeyemi I; Pollock RF J Med Econ; 2014 Jul; 17(7):520-6. PubMed ID: 24754700 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]